Log in
Enquire now
‌

US Patent 11406621 Pharmaceutical composition

Patent 11406621 was granted and assigned to Kowa Company, Ltd. on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Kowa Company, Ltd.
Kowa Company, Ltd.
0
Current Assignee
Kowa Company, Ltd.
Kowa Company, Ltd.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114066210
Patent Inventor Names
Akito Minamizono0
Shin Sugimoto0
Date of Patent
August 9, 2022
0
Patent Application Number
166271410
Date Filed
June 29, 2018
0
Patent Primary Examiner
‌
Paul V Ward
0
CPC Code
‌
A61K 31/423
0

Provided is a pharmaceutical composition containing pemafibrate, a salt thereof or a solvate thereof and having excellent homogeneity. The pharmaceutical composition is provided containing the following components (A) and (B): (A) pemafibrate, a salt thereof or a solvate thereof; and (B) a disaccharide species.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11406621 Pharmaceutical composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.